Why Choose Private Wegovy Over NHS Weight Management?
Wegovy Dosage Chart: Private vs NHS Prescription Routes
The Wegovy dosage chart remains identical whether prescribed privately or through NHS specialist weight management services, but the journey to access it differs dramatically. Through the NHS route, patients typically face GP referral to specialist weight management services, followed by 6+ month waiting lists and strict eligibility criteria reviews. Private prescription through EverydayMeds requires only a 3-minute online clinical assessment, prescriber review within 3 working days (24 hours express available), and next-day delivery of your Wegovy dosage chart starter pen.
Our private Wegovy dosage chart pathway ensures you receive the same genuine Novo Nordisk prescription-only medicine available through NHS services, manufactured to identical MHRA standards. The 5-dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) follows the same STEP trial protocol regardless of prescription route, with dose increases every 4 weeks to minimise gastrointestinal side effects. Private prescription eliminates the postcode lottery affecting NHS specialist weight management availability across different Clinical Commissioning Groups.
Complete Wegovy Dosage Chart Pricing and Bundle Options
Our transparent Wegovy dosage chart pricing structure eliminates hidden costs common with other private providers. Single pens start from £79.99 (0.25mg starter dose), progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 (2.4mg maintenance dose). Getting Started bundles provide convenient supply continuity: Intro Duo (0.25mg & 0.5mg) costs £169.99, while Progress Duo (0.5mg & 1mg) costs £189.99, both including next-day cold-chain delivery.
For patients following our Wegovy dosage chart long-term, Consistency bundles offer supply security with same-dose pairs: Consistency 0.25mg (×2) costs £139.99, ideal for patients requiring slower dose escalation. New customers apply discount code FIRST40 at checkout, while returning customers use code DOSE25, with final prices already reflected above. Our Ultimate Stability Trio (2.4mg ×3) provides 3 months maintenance supply for £649.99, ensuring uninterrupted treatment once you reach the final dosage chart level.
Wegovy Dosage Chart Clinical Evidence from STEP Trials
The Wegovy dosage chart protocol demonstrated in the STEP clinical trial programme shows significant weight management outcomes when used alongside a reduced-calorie diet and increased physical activity. In the landmark STEP 1 trial published by Wilding et al. in NEJM, 2021, participants following the complete dosage escalation to 2.4mg achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The 5-dose escalation schedule was specifically designed to optimise tolerability while maintaining efficacy.
STEP 2 trials demonstrated that patients with type 2 diabetes following the identical Wegovy dosage chart achieved approximately 9.6% weight reduction, while STEP 3 participants receiving intensive behavioural therapy alongside the dosage protocol achieved approximately clinically studied weight loss. These outcomes may vary significantly between individuals, and weight management results depend on adherence to both the dosage chart schedule and lifestyle interventions prescribed alongside treatment.
How Wegovy Works Throughout the Dosage Chart Escalation
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines after eating. The gradual dosage chart escalation from 0.25mg to 2.4mg allows your body to adapt to increased GLP-1 receptor activation, reducing appetite and promoting feelings of fullness after smaller meals. As you progress through each dosage level, semaglutide may help reduce food cravings by working on brain appetite centres, particularly areas controlling reward-driven eating behaviours. The 4-week intervals between dose increases allow gastrointestinal side effects to subside while building therapeutic efficacy. By the maintenance 2.4mg dose, patients typically experience optimal appetite suppression and satiety enhancement, supporting long-term weight management goals alongside dietary and exercise interventions.
Wegovy Dosage Chart Ordering Process Through EverydayMeds
Starting your Wegovy dosage chart journey requires completing our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our UK-registered prescribers review applications within 3 working days (express 24-hour service available), ensuring clinical appropriateness for the complete dosage escalation protocol. Once approved, your starter 0.25mg pen ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirement throughout transit. Our clinical team provides dosage chart guidance and ongoing support throughout your escalation journey, with automatic reminders for subsequent dose increases. The prescription-only medicine status requires prescriber approval for each dose level, ensuring clinical oversight throughout your weight management programme.
Wegovy Dosage Chart Storage and Practical Administration Guide
Proper storage throughout your Wegovy dosage chart progression ensures medication stability and efficacy across all dose levels. Unused pens require refrigeration at 2-8°C, though once removed from the fridge, each pen remains stable for up to 6 weeks at room temperature below 30°C - superior to Mounjaro's 21-day room temperature limit. The FlexTouch pen design remains consistent across all dosage chart levels, with dose selection clearly marked and click-counting for accurate administration. Each pen contains 4 doses, lasting exactly 4 weeks before progressing to the next dosage chart level. Never skip dose escalations or jump ahead in the dosage chart, as this increases side effect risks and may compromise treatment outcomes established in the STEP trial programme.
Private Wegovy Dosage Chart vs NHS Specialist Weight Management Pathways
NHS specialist weight management services follow identical Wegovy dosage chart protocols but access varies significantly by postcode, with some regions offering 6-month waiting lists while others exceed 12 months for initial consultation. Private prescription through EverydayMeds eliminates regional availability disparities, providing consistent access to the complete dosage escalation schedule nationwide. Our GPhC-registered pharmacy (#9012878) stocks all dosage chart levels continuously, preventing treatment interruptions common in NHS supply chains during high-demand periods.
Cost comparison shows NHS prescription charges of £9.90 per item (potentially £49.50 for complete dosage chart progression), while our private pricing provides transparent, all-inclusive costs with no hidden prescription fees or specialist consultation charges. Private prescription also eliminates the requirement for NHS specialist weight management service attendance, removing geographical barriers for patients in remote areas lacking local provision.
Starting Your Wegovy Dosage Chart Journey Today
Begin your private Wegovy dosage chart programme by completing our clinical assessment at https://everydaymeds.co.uk/collections/wegovy, designed specifically for UK patients seeking efficient weight management access. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 for continued savings throughout their dosage chart progression. Our regulated UK pharmacy operates under GPhC registration #9012878, ensuring pharmaceutical standards equivalent to NHS hospital pharmacy services but with private healthcare convenience and speed. Clinical assessment approval typically occurs within 72 hours, allowing you to start the proven STEP trial dosage protocol without lengthy NHS referral delays. Take control of your weight management journey today with transparent pricing, expert clinical oversight, and the convenience of next-day delivery for every stage of your Wegovy dosage chart progression.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
